spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

12th annual Cold Chain Distribution Conference and Exhibition

Cold Chain Distribution Conference and Exhibition

13-14 December 2017
Copthorne Tara Hotel, London, UK

As the global healthcare industry grows, temperature controlled logistics rapidly evolves along with it. Factors such as the ever-changing regulatory requirements, diverse array of biopharma products entering the markets, and new technology emerging daily, are causing companies to face the challenge of constantly adapting their supply chain processes and staying ahead of the curve.

Responding to the evolution within the industry, SMi is proud to announce the return of its leading 12th annual Cold Chain Distribution event. Returning to London in December, this year's event will remain at the forefront of innovation.

There has been a recent surge in temperature sensitive products entering the supply chain and the need for a streamlined temperature controlled supply chain has never been more important. Cold Chain Distribution 2017 looks at why companies must revisit their logistics, quality, and security procedures implemented to ensure they are keeping pace with this exponential growth. With huge interest from leaders in the field, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Cold Chain Distribution event.

The event will look at the fundamental question of how to keep costs low & quality high, while remaining compliant to global regulations.

 

Key topics for 2017 include:

  • GPS temperature monitoring 
  • Temperature data management 
  • Temperature controlled freight options 
  • GDP Regulatory Requirements
  • Identifying Future Trends


This year's event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers:

  • Tony Wright, CEO, Exelsius 
  • Bob Hayes, Director, SeerPharma (UK)  
  • Chris Wallace, Senior Director - International Supply Chain, Sanofi Genzyme 
  • David Spillett, Key Account Director, World Courier 
  • Mark Edwards, Managing Director, Modalis Ltd.  
  • Amélie Ermel, Production Senior Specialist Associate, Eli Lilly  
  • Stephanie Fitt, Sales Manager UK & Scandinavia, EMBALL'ISO 
  • Stephen Mitchell, Quality Lead Logistics Partnership, GlaxoSmithKline 
  • Umit Kartoglu, Scientist, World Health Organization 
  • Martin  Fitzgerald, Deputy Director General, European Association of Pharmaceutical Full Line-Wholesalers (GIRP) 
  • Glyn Stacey, Director of the UK Stem Cell Bank, National Institute For Biological Standards And Control 
  • Tim Wood, Technical Service Manager, GlaxoSmithKline 
  • Gianpiero Lorusso, Supply Chain Director, Merck S.p.A

12th annual Cold Chain Distribution Conference and Exhibition

13th -14th December 2017

Copthorne Tara Hotel, London, UK

Email: events@smi-online.co.uk

Tel: +44 (0) 207 827 6012

www.coldchain-distribution.com/samedan

 

phone Tel: +44 (0) 207 827 6012
email events@smi-online.co.uk
web www.coldchain-distribution.com/samedan
email Copthorne Tara Hotel, London, UK
 
Print this page
Send to a friend
   
spacer
Industry Events

Drug Delivery Partnerships 2018

22-24 January 2018, PGA National Resort & Spa, Palm Beach Gardens, Florida

For 22 years, DDP has been the world’s largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies.
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>


News and Press Releases

YHEC announces the promotions of Michelle Jenks and Rachael McCool to the role Project Director

YHEC is pleased to announce the promotions of Michelle Jenks from the Economic Modelling team and Rachael McCool from the Systematic Reviewing team to the role Project Director. Michelle has a Master’s degree (MSc) in health economics from the University of York and has conducted economic evaluations and systematic reviews for both public and private sector clients. Michelle is the lead modeller in YHEC’s role as an External Assessment Centre for NICE and has also led on a range of economic evaluations conducted for clients within industry, such as cost-utility models and budget impact models. She often leads the development of early economic analyses to inform clinical trial design and pricing strategy.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement